Shorea Lbg - Net Worth and Insider Trading

Shorea Lbg Net Worth

The estimated net worth of Shorea Lbg is at least $3.6 Billion dollars as of 2024-06-22. Shorea Lbg is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd and owns about 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) stock worth over $3.6 Billion. Details can be seen in Shorea Lbg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shorea Lbg has not made any transactions after 2024-04-10 and currently still holds the listed stock(s).

Transaction Summary of Shorea Lbg

To

Shorea Lbg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shorea Lbg owns 1 companies in total, including Luye Pharma Group Ltd (HKSE:02186) .

Click here to see the complete history of Shorea Lbg’s form 4 insider trades.

Insider Ownership Summary of Shorea Lbg

Ticker Comapny Transaction Date Type of Owner
HKSE:02186 Luye Pharma Group Ltd 2024-04-10 2201 Interest of corporation controlled by you

Shorea Lbg Latest Holdings Summary

Shorea Lbg currently owns a total of 1 stock. Shorea Lbg owns 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) as of April 10, 2024, with a value of $3.6 Billion.

Latest Holdings of Shorea Lbg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02186 Luye Pharma Group Ltd 2024-04-10 1,259,196,703 2.84 3,576,118,637

Holding Weightings of Shorea Lbg


Shorea Lbg Form 4 Trading Tracker

According to the SEC Form 4 filings, Shorea Lbg has made a total of 12 transactions in Luye Pharma Group Ltd (HKSE:02186) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Luye Pharma Group Ltd is the sale of 0 shares on April 10, 2024, which brought Shorea Lbg around $0.

Insider Trading History of Shorea Lbg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shorea Lbg Trading Performance

GuruFocus tracks the stock performance after each of Shorea Lbg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shorea Lbg is -16.72%. GuruFocus also compares Shorea Lbg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shorea Lbg within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Shorea Lbg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Shorea Lbg

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -22.49 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -27.47 LIMIT LIMIT LIMIT LIMIT LIMIT

Shorea Lbg Ownership Network

Ownership Network List of Shorea Lbg

No Data

Ownership Network Relation of Shorea Lbg

Insider Network Chart

Shorea Lbg Owned Company Details

What does Luye Pharma Group Ltd do?

Who are the key executives at Luye Pharma Group Ltd?

Shorea Lbg is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd. Other key executives at Luye Pharma Group Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2301 Trustee Liu Dianbo , and 2101 Beneficial owner LuYe Pharmaceutical Investment Co., Ltd. .

Luye Pharma Group Ltd (HKSE:02186) Insider Trades Summary

Over the past 18 months, Shorea Lbg made 10 insider transaction in Luye Pharma Group Ltd (HKSE:02186) with a net purchase of 2,000,000. Other recent insider transactions involving Luye Pharma Group Ltd (HKSE:02186) include a net sale of 73,433,500 shares made by UBS Group AG , a net purchase of 2,000,000 shares made by LuYe Pharmaceutical International Co., Ltd. , and a net purchase of 2,000,000 shares made by Nelumbo Investments Limited .

In summary, during the past 3 months, insiders sold 0 shares of Luye Pharma Group Ltd (HKSE:02186) in total and bought 3,569,500 shares, with a net purchase of 3,569,500 shares. During the past 18 months, 77,003,000 shares of Luye Pharma Group Ltd (HKSE:02186) were sold and 26,200,500 shares were bought by its insiders, resulting in a net sale of 50,802,500 shares.

Luye Pharma Group Ltd (HKSE:02186)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Luye Pharma Group Ltd Insider Transactions

No Available Data

Shorea Lbg Mailing Address

Above is the net worth, insider trading, and ownership report for Shorea Lbg. Currently GuruFocus does not have mailing address information for Shorea Lbg.

Discussions on Shorea Lbg

No discussions yet.